Global Dermatology Devices Market Estimated to be Valued at US$ 5,307.6 Mn by 2026
Dermatology devices market is a billion dollars market accounting for a substantial proportion of healthcare expenditure globally. In a new report titled “Dermatology Devices Market: Global Industry Analysis and Opportunity Assessment, 2016–2026” Future Market Insights offers a 10-year forecast for the global dermatology devices market and provides insights on the drivers, restraints, opportunities, and trends likely to govern the global dermatology devices market during the forecast period (2016 – 2026). According to Future Market Insights analysis, the global dermatology devices market is expected to reach US$ 2,708.4 Mn in terms of revenue by 2016 end, witnessing a year-over-year growth of 6.2%.
Dermatology Devices Market
Dermatology devices comprise lasers, RF devices, microdermabrasion devices, and other rela...
Factors such as rising prevalence of skin problems including acne leading to scars, increasing obesity, and growing aesthetic awareness among people are likely to contribute to the revenue growth of the global dermatology devices market over the forecast period. Economic factors such as growing healthcare expenditure, increasing disposable income per capita, and rising government support in developed economies are expected to boost the growth of the global dermatology devices market over the forecast period.
The global dermatology devices market is segmented on the basis of Product Type (Lasers, RF Devices, Microdermabrasion Devices, Others); Application (Vascular Lesions, Tattoo Removal, Hair Removal, Wrinkle Removal, Scar Removal, Acne Removal, Others); and End User (Hospitals, Specialty Dermatology Clinics, Private Clinics).
The Lasers product type segment is projected to dominate the global dermatology devices market in terms of value over the forecast period. This segment is anticipated to hold a market value share of 46.5% by the end of 2016
The RF Devices product type segment is expected to be the second most lucrative segment in the global dermatology devices market
The Vascular Lesions application segment is expected to account for 18.2% revenue share of the global dermatology devices market by 2016 end
The Hair Removal application segment is expected to reach US$ 915.6 Mn by 2026 owing to increase in prevalence of polycystic ovarian syndrome in women
The Speciality Dermatology Clinics end user segment is anticipated to reach a market valuation of US$ 2,005.3 Mn by 2026
The Private Clinics end user segment is expected to account for 30.3% revenue share of the global dermatology devices market by 2016 end
Regional market projections
The global dermatology devices market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The demand for non-invasive cosmetic correction procedures has been significantly high in the U.S. market in the recent years, making North America the most lucrative market globally. In addition to North America, demand for non-invasive cosmetic procedures has been significantly growing in Western Europe and APEJ. Western Europe is expected to account for 20.3% revenue share of the global dermatology devices market by 2016 end.
The global dermatology devices market report profiles some of the leading companies operating in the global dermatology devices market such as Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis, Syneron Candela Ltd., Avita Medical Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Cutera, Lutronics Corporation, and Beijing Toplaser Technology Co. Ltd. Major market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Lumenis acquired Pollogen to strengthen and expand its aesthetic products portfolio. Similarly, in May 2016, Alma Lasers launched Accent Prime that combines ultrasound and unipolar radio frequency technologies to provide enhanced body contouring and skin tightening treatments.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
- Global Digital Pathology Market
- Healthcare Regulatory Affairs Outsourcing Market
- Cold Plasma Market
- Hdl Cholesterol Kits Market
- Single Dose Radiotherapy Services Market
- General Anesthesia Drugs Market
- Clinical Trials Market
- Injectable Drug Delivery Market
- Microfluidics Market
- Lab Automation Market
- Lung Cancer Surgery Market
- Veterinary Vaccines Market
- Prescription Delivery Services Market
- Vital Signs Monitoring Devices Market
- Weight Loss And Obesity Management Market